What happens if you take too much Wegovy?

Wegovy is dosed as a once-weekly subcutaneous injection; taking it twice in one week, or at the wrong strength, counts as an overdose even if symptoms seem mild at first.
The most common effects of too much semaglutide are gastrointestinal: intense nausea, vomiting, diarrhoea, or abdominal pain, which may be worse than anything experienced at a normal dose.
Severe, persistent stomach pain that spreads to the back (with or without vomiting) needs urgent medical assessment, as it can signal pancreatitis, a known but uncommon risk with GLP-1 medicines.
Your prescriber or pharmacist should always be told if you take more than your prescribed dose, even if you feel fine afterwards, so your ongoing plan can be reviewed.

Taking too much Wegovy — whether a double dose, a mistimed injection, or simply more than your prescriber intended — typically causes a sharp increase in gastrointestinal symptoms: nausea, vomiting, or stomach pain that arrives sooner and more intensely than usual. It is rarely a medical emergency, but it does need careful attention and, in some cases, prompt medical contact. Wegovy (semaglutide) is a prescription-only medicine, and your dose is set by a clinician for a reason: the titration schedule exists specifically to limit these effects while your body adjusts. If you suspect you have taken more than prescribed, the steps below will help you understand what to expect and what to do.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Understanding what 'too much Wegovy' looks like, and what to do about it

What are the signs that you have taken too much?

The most immediate signal is a strong wave of nausea, often arriving within a few hours of the injection. At the correct dose, most people experience some nausea, particularly in the first week or two of a new strength. When the dose is higher than intended, that effect tends to arrive faster, feel more intense, and last longer. Vomiting, diarrhoea, and an uncomfortable feeling of fullness or bloating are also common, and if you have eaten a large meal before or after your injection, our guide on eating too much on Wegovy explains how that can make these symptoms considerably worse.

Beyond the stomach, some people notice dizziness or a general feeling of being unwell. These effects are unpleasant but usually pass within a day or two as semaglutide continues to move through your system. The medicine has a long half-life, so a single extra dose does not simply disappear quickly.

The symptom that should prompt you to seek medical attention without delay is severe, persistent abdominal pain, particularly if it radiates towards your back. The MHRA issued a Drug Safety Update in January 2026 specifically highlighting acute pancreatitis as a known, though infrequent, risk with GLP-1 receptor agonist medicines, and this is the presentation to watch for. If you experience that kind of pain, call 111 or go to your nearest urgent care centre. Do not wait to see whether it settles on its own.

For a fuller account of what to do in the immediate period after an accidental overdose, our guide on the next steps after taking too much Wegovy covers the practical sequence clearly.

Why do some people accidentally take too much Wegovy?

The most common scenario is a genuinely forgotten injection. Someone who is not certain whether they gave themselves their weekly dose decides to administer it anyway, meaning the same week's dose is delivered twice. The NHS advises that if you miss a dose and more than five days of the seven-day window remain, you take it as soon as you remember; if fewer than five days remain, you skip it and continue on your usual day. Repeating a dose to be safe is never the right move, and our page for people who have already taken too much Wegovy sets out the immediate steps to follow if this has happened to you.

A second scenario involves using the wrong strength pen. Wegovy comes in several dose strengths along the titration path, and a mix-up between last month's remaining pens and the new delivery can mean injecting a higher amount than intended. Getting into the habit of checking the label on the pen before each injection (it takes under a minute) is a simple and effective way to avoid this. The strength is printed clearly on both the pen itself and the outer carton.

Some people have also taken a full injection on top of a partial one, believing the first pen had not delivered the dose. If there is any doubt about delivery, the default position is to assume the dose was given rather than repeat it. The semaglutide overview on our site has more on how the Wegovy pen mechanism works and what a completed injection looks like.

Occasionally, confusion arises when someone is transferring from a different medicine or service and misreads their new starting dose. Transfer patients should always have their dose confirmed in writing before their first injection at the new provider.

Does taking too much Wegovy affect your ongoing treatment?

In most cases, a single accidental overdose does not derail a treatment plan, but it does need to be flagged, and our dedicated page on taking too much Wegovy covers what to tell your prescriber and how the review process typically unfolds. Your prescriber may recommend delaying the next injection by a day or two if you are still symptomatic, or they may ask you to step back to the previous dose if the reaction was particularly difficult. These are clinical decisions that should not be made unilaterally.

The concern with repeated overdosing, or with systematically using a higher dose than prescribed in the hope of faster results, is more significant. Semaglutide's dose ladder exists because tolerability and safety both depend on a gradual increase. Jumping ahead increases the likelihood of severe nausea and vomiting that leads to dehydration, which in turn can put strain on the kidneys. Sustained dehydration from repeated GI illness is one of the risk patterns the NHS highlights for people taking weight-management injections.

There is also a practical point about your treatment record. At nume, every repeat order goes through a fresh clinical review by a GPhC-registered prescriber before anything is dispensed. If a pattern of symptoms suggests the current dose is not being tolerated, that review is the point at which your plan gets adjusted rather than simply continued. If you are experiencing persistent side effects, our aftercare team is available seven days a week and can route your question to a prescriber the same day.

For those who are curious about how semaglutide compares to other options and what the prescribing considerations look like, the weight-loss treatment overview lays out the landscape without pushing any single route.

Should you be concerned about the long-term safety of Wegovy at the right dose?

This question comes up often when someone has had a scare with an accidental overdose: if one extra injection caused that much nausea, is the medicine safe to continue? The short answer, based on the clinical evidence, is that Wegovy at the prescribed dose has a well-characterised safety profile across large trials, and if you want a broader look at how dosing limits are established, our page on whether you can take too much semaglutide explains the pharmacology behind those boundaries. The STEP 1 trial, published in the New England Journal of Medicine, followed adults on 2.4mg semaglutide for 68 weeks; gastrointestinal side effects were the most common adverse event, but serious events were uncommon and the medicine was stopped for side effects by a relatively small proportion of participants.

At the correct dose, nausea tends to ease once your body has had a few weeks to adjust at each level. That is precisely why the titration schedule starts low and moves slowly. An episode of too much Wegovy, unpleasant as it is, does not typically mean the medicine is wrong for you. It usually means the dose schedule needs to be respected more carefully going forward.

The NHS medicines page for semaglutide is a reliable first reference for side-effect information, including guidance on which symptoms are worth monitoring and which need urgent attention. If you have questions about whether Wegovy is still the right option after an accidental overdose, our prescribers are the right people to ask. Starting a free consultation with our clinical team is the straightforward way to get a considered answer.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions